Our long-term study of CAV1 found that it is complex and flexible in IBD, and the mechanism by which CAV1 modulates inflammation differs in different populations of colon cells, such as fibroblasts, endothelial cells and epithelial cells [6, 30]. This evidence concerns the gene CAV1 and inflammatory bowel disease.